Analyst Ratings for Corvus Pharmaceuticals (CRVS)
CRVS Rating Summary
CRVS Price Target Summary
- Highest: $42.00 (Jefferies)
- Lowest: $27.00 (H.C. Wainwright)
- Average: $33.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$33.14 (+129.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$33.14 (+129.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/29/2026 | Ladenburg Thalmann | Kevin DeGeeter | New Coverage | Buy (N/A) |
32.00 (N/A) |
13.31 (14.42) |
8.34% | Details |
| 4/17/2026 | Goldman Sachs | Paul Choi | New Coverage | Buy (N/A) |
40.00 (N/A) |
15.11 (14.42) |
-4.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
